Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH
Abstract Introduction Excess body fat is linked to higher risks for metabolic syndrome, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CV), among other health conditions. However, it is not only the level but also the distribution of body fat that contributes to increased disease risks...
Main Authors: | Adrian Vilalta, Julio A. Gutiérrez, SuZanne Chaves, Moisés Hernández, Silvia Urbina, Marcus Hompesch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | Endocrinology, Diabetes & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1002/edm2.335 |
Similar Items
-
A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity
by: Óscar Osorio-Conles, et al.
Published: (2021-09-01) -
Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review
by: Lydie Carreres, et al.
Published: (2021-04-01) -
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer
by: Yetirajam Rajesh, et al.
Published: (2021-02-01) -
Metabolic drivers of non-alcoholic fatty liver disease
by: Kendra K. Bence, et al.
Published: (2021-08-01) -
Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
by: Alexandre Losekann, et al.
Published: (2015-10-01)